finder.com.au

How to buy Kazia Therapeutics shares

Own Kazia Therapeutics shares in just a few minutes.

Updated

Fact checked

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Kazia Therapeutics Limited is a biotechnology business based in Australia. Kazia Therapeutics shares (KZA) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Kazia Therapeutics has a trailing 12-month revenue of around $988,110..

How to buy shares in Kazia Therapeutics

  1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for Kazia Therapeutics . Find the share by name or ticker symbol: KZA. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Kazia Therapeutics reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price of $0.815, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of Kazia Therapeutics . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

What's in this guide?

  1. Kazia Therapeutics key stats
  2. Compare share trading platforms
  3. Is Kazia Therapeutics stock a buy or sell?
  4. Kazia Therapeutics performance over time
  5. Kazia Therapeutics 's financials
  6. How volatile are Kazia Therapeutics shares?
  7. Does Kazia Therapeutics pay a dividend?
  8. Have Kazia Therapeutics shares ever split?
  9. Other common questions

Kazia Therapeutics share price

Use our graph to track the performance of KZA stocks over time.

Kazia Therapeutics shares at a glance

Information last updated 2020-10-22.
52-week range$0.37 - $1.235
50-day moving average $0.9129
200-day moving average $0.6308
Target price$0.22
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.179

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

  • Brokerage - AU shares: From AUD 5 or 0.05%
  • Brokerage - US shares: USD 0
  • Sign-up process: Instant
  • Support - After hours: Yes
Go to site
More info

Important: Share trading carries risk of capital loss.

Promoted

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Data indicated here is updated regularly
Name Product Standard brokerage fee Inactivity fee Markets
IG Share Trading
Finder Award
IG Share Trading
AUD 8 or 0.1%
AUD 50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares, Forex, CFDs, Margin trading
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, forex and CFDs, plus get access to 24-hour customer support.
Go to site
More Info
Bell Direct Share Trading
Finder Award
Bell Direct Share Trading
AUD 15
No
ASX shares, Options trading, mFunds, ETFs, Warrants
Invest in Australian shares, options and managed funds from the one account with no inactivity fee.
Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.
Go to site
More Info
Superhero share trading
Superhero share trading
AUD 5
No
ASX shares, ETFs
Pay zero brokerage on all Australian ETFs.
Trade ASX stocks with a flat $5 commission fee and a low minimum investment of just $100.
Go to site
More Info
CMC Markets Stockbroking
Finder Award
CMC Markets Stockbroking
AUD 11 or 0.1%
No
ASX shares, Global shares, Forex, CFDs, Options trading, mFunds, ETFs, Warrants
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, managed funds, forex, commodities and cryptocurrencies, plus access up to 15 major global and Australian stock exchanges.
Go to site
More Info
SelfWealth Share Trading (Basic account)
SelfWealth Share Trading (Basic account)
AUD 9.5
No
ASX shares, US shares
Trade ASX and US shares for a flat fee of $9.50, regardless of the trade size.
New customers receive free access to Community Insights with SelfWealth Premium for the first 90 days. Follow other investors and benchmark your portfolio performance.
Go to site
More Info
ANZ Share Investing
ANZ Share Investing
AUD 19.95
No
ASX shares, Global shares, Options trading, mFunds, ETFs, Warrants
Earn 1 Qantas Point per AU$3 spent on brokerage fees on certain instruments.
Access Morningstar reports, company announcements and and live pricing via ANZ’s share investing platform. Available for desktop and mobile.
More Info
Westpac Online Investing Account
Westpac Online Investing Account
AUD 19.95 or 0.11%
USD 63.50 per year on the global markets account
ASX shares, Global shares, Options trading, ETFs
More Info
loading

Compare up to 4 providers

Is it a good time to buy Kazia Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Kazia Therapeutics Limited by TradingView

Kazia Therapeutics price performance over time

Historical closes compared with the close of A$0.815 on 2020-10-22

1 week (2021-01-14) -40.51%
1 month (2020-12-21) -30.34%
3 months (2020-10-21) -2.98%
6 months (2020-07-21) 48.18%
1 year (2020-01-21) 30.40%
2 years (2019-01-21) 94.05%
3 years (2018-01-19) 81.11%
5 years (2016-01-21) -29.13%

Kazia Therapeutics financials

Revenue TTM $988,110
Gross profit TTM $988,110
Return on assets TTM -34.45%
Return on equity TTM -88.05%
Profit margin 0%
Book value 0.149
Market capitalisation $93.8 million

TTM: trailing 12 months

Kazia Therapeutics share dividends

We're not expecting Kazia Therapeutics to pay a dividend over the next 12 months.

Have Kazia Therapeutics 's shares ever split?

Kazia Therapeutics 's shares were split on a 1:10 basis on 17 November 2017. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Kazia Therapeutics shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Kazia Therapeutics shares which in turn could have impacted Kazia Therapeutics 's share price.

Kazia Therapeutics share price volatility

Over the last 12 months, Kazia Therapeutics 's shares have ranged in value from as little as $0.37 up to $1.235. A popular way to gauge a stock's volatility is its "beta".

KZA.AU volatility(beta: 2.13)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Kazia Therapeutics 's is 2.133. This would suggest that Kazia Therapeutics 's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Kazia Therapeutics overview

Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. Kazia Therapeutics Limited has collaboration with Dana-Farber Cancer Institute to investigate the use of Kazia's investigational new drug, paxalisib, in primary central nervous system lymphoma. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is based in Sydney, Australia.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site